New drug doubles time before breast cancer grows in a trial
A new drug, iza-bren, doubled the time some breast cancer patients lived before their disease got worse. In a trial from China, it rose from 4 months on chemotherapy to 8.2 months. The patients had HR-positive breast cancer. The drug also caused more serious side effects. Results came out at a meeting in Madrid.
Where this came from. One outlet reported this. We read it, then wrote the sixty words above.